The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology

Abstract Background The WNT pathway regulates intestinal stem cells and is frequently disrupted in intestinal adenomas. The pathway contains several potential biotargets for interference, including the poly-ADP ribosyltransferase enzymes tankyrase1 and 2. LGR5 is a known WNT pathway target gene and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Norum,Jens Henrik, Skarpen,Ellen, Brech,Andreas, Kuiper,Raoul, Waaler,Jo, Krauss,Stefan, Sørlie,Therese
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2018
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100203
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602018000100203
record_format dspace
spelling oai:scielo:S0716-976020180001002032018-03-09The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphologyNorum,Jens HenrikSkarpen,EllenBrech,AndreasKuiper,RaoulWaaler,JoKrauss,StefanSørlie,Therese Tankyrase inhibitor LGR5 WNT signalling Intestine Lineage tracing Stem cell Abstract Background The WNT pathway regulates intestinal stem cells and is frequently disrupted in intestinal adenomas. The pathway contains several potential biotargets for interference, including the poly-ADP ribosyltransferase enzymes tankyrase1 and 2. LGR5 is a known WNT pathway target gene and marker of intestinal stem cells. The LGR5+ stem cells are located in the crypt base and capable of regenerating all intestinal epithelial cell lineages. Results We treated Lgr5-EGFP-Ires-CreERT2;R26R-Confetti mice with the tankyrase inhibitor G007-LK for up to 3 weeks to assess the effect on duodenal stem cell homeostasis and on the integrity of intestinal epithelium. At the administered doses, G007-LK treatment inhibited WNT signalling in LGR5+ stem cells and reduced the number and distribution of cells traced from duodenal LGR5+ stem cells. However, the gross morphology of the duodenum remained unaltered and G007-LK-treated mice showed no signs of weight loss or any other visible morphological changes. The inhibitory effect on LGR5+ stem cell proliferation was reversible. Conclusion We show that the tankyrase inhibitor G007-LK is well tolerated by the mice, although proliferation of the LGR5+ intestinal stem cells was inhibited. Our observations suggest the presence of a tankyrase inhibitor-resistant cell population in the duodenum, able to rescue tissue integrity in the presence of G007-LK-mediated inhibition of the WNT signalling dependent LGR5+ intestinal epithelial stem cells.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.51 20182018-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100203en10.1186/s40659-017-0151-6
institution Scielo Chile
collection Scielo Chile
language English
topic Tankyrase inhibitor
LGR5
WNT signalling
Intestine
Lineage tracing
Stem cell
spellingShingle Tankyrase inhibitor
LGR5
WNT signalling
Intestine
Lineage tracing
Stem cell
Norum,Jens Henrik
Skarpen,Ellen
Brech,Andreas
Kuiper,Raoul
Waaler,Jo
Krauss,Stefan
Sørlie,Therese
The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
description Abstract Background The WNT pathway regulates intestinal stem cells and is frequently disrupted in intestinal adenomas. The pathway contains several potential biotargets for interference, including the poly-ADP ribosyltransferase enzymes tankyrase1 and 2. LGR5 is a known WNT pathway target gene and marker of intestinal stem cells. The LGR5+ stem cells are located in the crypt base and capable of regenerating all intestinal epithelial cell lineages. Results We treated Lgr5-EGFP-Ires-CreERT2;R26R-Confetti mice with the tankyrase inhibitor G007-LK for up to 3 weeks to assess the effect on duodenal stem cell homeostasis and on the integrity of intestinal epithelium. At the administered doses, G007-LK treatment inhibited WNT signalling in LGR5+ stem cells and reduced the number and distribution of cells traced from duodenal LGR5+ stem cells. However, the gross morphology of the duodenum remained unaltered and G007-LK-treated mice showed no signs of weight loss or any other visible morphological changes. The inhibitory effect on LGR5+ stem cell proliferation was reversible. Conclusion We show that the tankyrase inhibitor G007-LK is well tolerated by the mice, although proliferation of the LGR5+ intestinal stem cells was inhibited. Our observations suggest the presence of a tankyrase inhibitor-resistant cell population in the duodenum, able to rescue tissue integrity in the presence of G007-LK-mediated inhibition of the WNT signalling dependent LGR5+ intestinal epithelial stem cells.
author Norum,Jens Henrik
Skarpen,Ellen
Brech,Andreas
Kuiper,Raoul
Waaler,Jo
Krauss,Stefan
Sørlie,Therese
author_facet Norum,Jens Henrik
Skarpen,Ellen
Brech,Andreas
Kuiper,Raoul
Waaler,Jo
Krauss,Stefan
Sørlie,Therese
author_sort Norum,Jens Henrik
title The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
title_short The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
title_full The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
title_fullStr The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
title_full_unstemmed The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
title_sort tankyrase inhibitor g007-lk inhibits small intestine lgr5+ stem cell proliferation without altering tissue morphology
publisher Sociedad de Biología de Chile
publishDate 2018
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100203
work_keys_str_mv AT norumjenshenrik thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT skarpenellen thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT brechandreas thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT kuiperraoul thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT waalerjo thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT kraussstefan thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT sørlietherese thetankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT norumjenshenrik tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT skarpenellen tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT brechandreas tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT kuiperraoul tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT waalerjo tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT kraussstefan tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
AT sørlietherese tankyraseinhibitorg007lkinhibitssmallintestinelgr5stemcellproliferationwithoutalteringtissuemorphology
_version_ 1718441568780681216